Pharmaceutical company in the
Canton of Valais
54 companies in Pharmaceutical company based in the Canton of Valais — name and year of registration from the commercial register.
50 of 54 companies
Naturalpes Pharma SA
Since 2023 · 1–10 empl.4.9(259)
Naturalpes Pharma SA develops and sells hemp-derived CBD products, including oils, flowers, cosmetics, resins and herbal infusions. It supplies customers directly and offers wholesale products to business partners.
PharmAlp SA
Since 2011 · 11–20 empl.4.9(10)
PharmAlp SA develops and sells natural health products based on phytotherapy and probiotics. Its range includes products for iron intake, cardiovascular health, energy, immune support, microbiota, sleep and women’s health.
Valsynthese SA
Since 1983 · 101–500 empl.5.0(4)
Valsynthese SA provides custom synthesis and contract manufacturing for the chemical and pharmaceutical industries. It develops and produces chemical intermediates and active pharmaceutical ingredients, with expertise in high-risk reactions and the handling of hazardous substances.
Debiopharm Research & Manufacturing SA
Since 1988 · 101–500 empl.4.3(4)
Debiopharm Research & Manufacturing SA is a pharmaceutical research, development and production facility. Its work includes drug formulation and delivery technologies, such as injectable sustained-release systems and nanoparticular drug delivery systems.
TRB CHEMEDICA SA
Since 1964 · 101–500 empl.4.2(11)
TRB CHEMEDICA SA is a pharmaceutical company that manufactures and sells pharmaceutical and biotechnology products. It develops and produces hyaluronic acid-based products, particularly for ophthalmology and rheumatology, including treatments for dry eye and joint and tendon conditions.
Excellgene SA
Since 2004 · 11–20 empl.5.0(1)
ExcellGene is a Swiss Biologics-CDMO (Contract Development and Manufacturing Organization) specialized in the development and manufacturing of proteins for the pharmaceutical industry. The company's core activity encompasses providing services for the development and manufacturing of biologics, including: cell line development (CHO and HEK cells), genome engineering, cGMP cell banking, process development, ensuring clonality of existing cell lines, and biosimilars. The company supports pharmaceutical companies in the development and manufacturing of proteins for drug development, offering a combination of scientific expertise and technological infrastructure.
BioAtrium AG
Since 2017 · 101–500 empl.4.8(4)
BioAtrium AG is a joint venture between Lonza and Sanofi that operates a biopharmaceutical mammalian cell culture production facility. It develops, manufactures and supplies biopharmaceutical cell culture products and active ingredients for biologic medicines.
Bachem SA, succursale de Vionnaz
Since 2011 · 101–500 empl.4.5(4)
Bachem SA, succursale de Vionnaz operates a GMP manufacturing site for active pharmaceutical ingredients. Its activities include producing small-molecule and generic APIs, short peptides, and amino acid derivatives.
Siegfried Evionnaz SA
Since 2015 · 101–500 empl.3.8(13)
Siegfried Evionnaz SA specializes in the custom synthesis of active pharmaceutical ingredients and intermediates. Its services include chemical process development, analytical development and scale-up to industrial manufacturing.
IHMA Europe Sàrl
Since 2009 · 21–50 empl.5.0(1)
IHMA Europe Sàrl supports the development of antimicrobial medicines through clinical research and microbiology laboratory services. Its work includes clinical trials, antimicrobial resistance surveillance, and scientific and regulatory support.
Phytocon GmbH
Since 1997 · 1–10 empl.
Phytocon GmbH distributes selected brands in Switzerland, including natural cosmetics, food supplements and other product categories. It supports brands entering the Swiss market and provides warehousing, logistics and distribution.
Straqim SA
Since 2001 · 21–50 empl.
Straqim SA distributes active pharmaceutical ingredients (APIs) and develops, registers and distributes ingredients for consumer health products. It also provides contract manufacturing and international API supply services.
BAXTER Group AG
Since 2009 · 21–50 empl.
BAXTER Group AG is a healthcare company that supplies medical devices, injectable medicines and clinical nutrition products for hospital, renal and surgical care.
Phi Pharma SA
Since 2011 · 11–20 empl.
Phi Pharma SA develops peptide-drug conjugates (PDCs) for cancer treatment. Its technology is designed to deliver therapeutic payloads into targeted cancer cells, and its development programmes address both solid and liquid tumours.
INFLAMALPS SA
Since 2012 · 11–20 empl.
INFLAMALPS SA is a biopharmaceutical company researching and developing anti-inflammatory and antimicrobial molecules. Its work includes developing INF101 for the topical treatment of dry eye and searching for new molecules against multidrug-resistant microbes.
BE-CEUTICALS SA
Since 2013 · 11–20 empl.
BE-CEUTICALS SA is a company specialising in aesthetic medicine and skincare. It develops and markets injectable hyaluronic acid fillers, skin booster serums and dermocosmetic skincare products.
Swiss Biotech Center SA
Since 2016 · 11–20 empl.
Swiss Biotech Center SA develops and manufactures biopharmaceutical products, from research and development through clinical development. Its services include producing clinical batches of biologics to cGMP standards and supporting start-ups and project teams.
Celluris AG
Since 2016 · 21–50 empl.
Celluris AG develops cancer immunotherapies based on CAR-T cell therapy. Its research focuses on personalized treatments for hematological and solid tumors.
Straqim Holding SA
Since 2018 · 11–20 empl.
Straqim Holding SA distributes bulk active pharmaceutical ingredients (APIs) and provides contract manufacturing, sourcing and international supply services for pharmaceutical substances. The company also develops, registers and commercializes ingredients for the consumer health market.
Swiss Health Medical Sàrl
Since 2019 · 21–50 empl.
Swiss Health Medical Sàrl operates an online shop offering dietary supplements and health products from the Vita range, including collagen, omega and protein formulations as well as products for joints, immune support and weight management.
CeiROx Life Sciences SA
Since 2007 · 1–10 empl.
CeiROx Life Sciences SA is a company active in the life sciences sector. The website provides only contact details and does not describe specific products or services.
BioXpress Therapeutics SA
Since 2008 · 11–20 empl.
The core activity of BioXpress Therapeutics SA is the development and manufacturing of biosimilars, in particular monoclonal antibodies (mAb), as well as other biological medicines, including gene therapy and cell therapy candidates. The company focuses on developing high-quality, sustainably manufactured biosimilars that aim to improve access to life-saving treatments and reduce healthcare costs.
ImmunSkills SA
Since 2022 · 11–20 empl.
ImmunSkills SA develops allogenic cell‑based therapies for solid cancers, aiming to create a product using allogenic cells that can kill various cancer cells and modify the tumour microenvironment to reduce treatment resistance.
ten23 health Valais AG
Since 2013 · 51–100 empl.3.7(11)
ten23 health Valais AG is a CDMO serving the pharmaceutical industry and biotech start-ups. The company provides pharmaceutical product development, sterile drug manufacturing (fill and finish), and analytical testing and quality control services.
Stämm Vegh SA
Since 2023 · 1–10 empl.
Stämm Vegh SA distributes bioprocessors and biotechnology solutions for the production of biologics and cell therapies. Its activities include continuous automated biomanufacturing, cell line development solutions, and AI-based analysis of biological data.
Ceres Heilmittel AG
Since 2011 · 1–10 empl.5.0(1)
Ceres Heilmittel AG manufactures herbal medicinal products, including mother tinctures made from fresh medicinal plants using the Ceres mortar process. Its range also includes complex remedies and specialised skincare products.
Orio Therapeutics SA
Since 2023 · 1–10 empl.
Orio Therapeutics SA develops medical therapies using protein engineering and regenerative medicine. It modifies therapeutic proteins to control their delivery and localization, with an initial focus on treatments for patients following a heart attack.
ExcellGene Group SA
Since 2025 · 1–10 empl.
NUTRICRAFT SA
Since 2025 · 21–50 empl.5.0(1)
NUTRICRAFT SA develops and manufactures dietary supplements and nutraceutical products for brands and health professionals. Its services include formula development, production of capsules, tablets and powders, quality control, packaging and logistics.
Mon Labo SA
Since 2026 · 1–10 empl.
Mon Labo SA is an independent pharmacy specializing in complementary medicine, including aromatherapy, phytotherapy and homeopathy. It also operates in-house laboratories for homeopathic and other custom preparations, and offers a range of house-made products.
Mélane Consulting GmbH
Since 2025 · 1–10 empl.
Mélane Consulting GmbH is a consultancy specialising in computer system validation (CSV) and commissioning, qualification and validation (CQV) for the pharmaceutical and biotech industries. It provides support for AI, cloud and GxP system validation, regulatory compliance, and audit readiness.
Lonza AG
101–500 empl.
Lonza AG is a contract development and manufacturing company serving the healthcare industry. It provides integrated services for biologics, small molecules, bioconjugates, and specialized modalities such as cell and gene therapies, mRNA, and microbial processes.
Damir Vejapi Elysium PharmaTech
1–10 empl.
Damir Vejapi Elysium PharmaTech provides cleanroom and technical insulation for pharmaceutical and biotechnology businesses and laboratories. Its services include planning and installing closed-cell PVDF foam insulation without tape or adhesive.
Homeolab SA
Since 1995 · 1–10 empl.
DSM Nutritional Products AG Zweigniederlassung Werk Lalden
Since 2004 · 1–10 empl.
SILDERMA SARL
Since 2007 · 1–10 empl.
Omnipharm SA
Since 2012 · 1–10 empl.
Kahn Partners Equity Sàrl
Since 2014 · 1–10 empl.
Xcential Sàrl
Since 2015 · 1–10 empl.
Caravella Biopharma SA
Since 2016 · 1–10 empl.
Sacoda PharmConsult GmbH
Since 2017 · 1–10 empl.
EVOLEINA RHODIOLA Sàrl
Since 2019 · 1–10 empl.
Kodiak Sciences Valais GmbH
Since 2020 · 1–10 empl.
IBEX Therapeutics SA
Since 2021 · 1–10 empl.
Leander Hertli Consulting
Since 2022 · 1–10 empl.
Platinum Solutions Sàrl
Since 2023 · 1–10 empl.
Precise Health SA
Since 2023 · 1–10 empl.
CorLinker Biotech GmbH
Since 2024 · 1–10 empl.
Pro Sanitate SA
Since 2024 · 1–10 empl.
Catherine Dieudonné Tivollier TPH PARTNER
Since 2025 · 1–10 empl.
Pharmaceutical company in the Canton of Valais
Pharmaceutical company in other places
By canton